GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	5.93B
Revenue (ttm)	3.52B
Net Income (ttm)	146.49M
Shares Out	83.51M
EPS (ttm)	1.75
PE Ratio	40.49
Forward PE	n/a
Dividend	0.75 (1.06%)
Ex-Dividend Date	n/a

Volume	682,566
Average Volume	257,548
Open	68.46
Previous Close	68.46
Day's Range	67.70 - 73.00
52-Week Range	32.66 - 81.50
Beta	0.90
RSI	73.47
Earnings Date	Nov 13, 2025

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2024, GlaxoSmithKline S.A.E's revenue was 2.99 billion, an increase of 33.51% compared to the previous year's 2.24 billion. Earnings were 173.98 million, an increase of 187.78%.